Lv1
40 积分 2024-02-28 加入
Effects of CYP2D6 *10 and *41 Variants in Healthy Chinese Men on the Pharmacokinetics of Dapoxetine
1个月前
已完结
Assessment of the Implementation of AUC Dosing and Monitoring Practices With Vancomycin at Hospitals Across the United States
3个月前
已完结
Unbound serum polymyxin B in patients with sepsis: Detection approaches and limited sampling strategy for clinical practice and research
7个月前
已完结
Identification of vancomycin exposure target in neonates: how much is enough?
11个月前
已完结
Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial
11个月前
已完结
Intravenous polymyxin B for the treatment of nosocomial pneumonia caused by multidrug-resistant Pseudomonas aeruginosa
11个月前
已完结
Population pharmacokinetics of polymyxin B in patients with liver dysfunction
1年前
已完结
Population Pharmacokinetic Modeling Using Polymyxin B Free Plasma Concentrations From Published Reports and Evaluation of Dosage Regimens Based on Monte Carlo Simulation in Critically Ill Patients
1年前
已完结
Daily fluid intake as a novel covariate affecting the population pharmacokinetics of polymyxin B in patients with sepsis
1年前
已完结
The population pharmacokinetics and dose optimization of polymyxin B in critically ill patients with or without extracorporeal membrane oxygenation
1年前
已完结
皖公网安备34019202002308
